Cargando…
Decrease in Chitinase 3-Like Protein 1 Levels Reflects Improvement in Liver Fibrosis after HCV Eradication
AIM: The success of direct-acting antivirals (DAAs) against hepatitis C virus is a major breakthrough in hepatology. Previous studies have shown that chitinase 3-like protein 1 (CHI3L1) was a marker for staging of liver fibrosis caused by HCV. In this investigation, we used CHI3L1 as a surrogate mar...
Autores principales: | Kang, Qian, Chen, Jianhong, Luo, Hao, Tan, Ning, Gao, Hui, Zhang, Xiaxia, Yu, Min, Liu, Dan, Xi, Hongli, An, Yaoyu, Han, Yifan, Cheng, Ran, Xu, Xiaoyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556050/ https://www.ncbi.nlm.nih.gov/pubmed/33082884 http://dx.doi.org/10.1155/2020/8539804 |
Ejemplares similares
-
Changes in renal function indices in cirrhotic chronic hepatitis C patients treated with sofosbuvir-containing regimens
por: Chen, Jianhong, et al.
Publicado: (2017) -
Resistant-Associated Substitutions Do Not Affect HCV RNA and HCV Core Antigen Clearance During Direct-Acting Antiviral Agent Treatment in a Real-World Setting
por: Chen, Hongyu, et al.
Publicado: (2022) -
Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis
por: Lee, Suh-Young, et al.
Publicado: (2022) -
Chitinases and chitinase-like proteins as biomarkers in neurologic
disorders
por: Pinteac, Rucsanda, et al.
Publicado: (2020) -
Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna
por: Steiner, Sebastian, et al.
Publicado: (2017)